Log In
Print this Print this

Fentanyl transdermal system (HFG-512)

  Manage Alerts
Collapse Summary General Information
Company Hisamitsu Pharmaceutical Co. Inc.
Description72 hours matrix type transdermal fentanyl patch
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat chronic pain
Regulatory Designation
PartnerApotex Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today